FMR LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 1,251,766 2.200% | -3,902,148 (-75.71%) | Filing |
| 2025-11-05 11:26 am Sale | 2025-09-30 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 5,153,914 9.100% | -1,782,852 (-25.70%) | Filing |
| 2025-05-12 10:10 am Sale | 2025-03-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 6,936,766 12.300% | -886,963 (-11.34%) | Filing |
| 2025-02-12 08:46 am Purchase | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 7,823,729 13.900% | 7,823,729 (New Position) | Filing |